Results 41 to 50 of about 4,429 (159)
Human UPF1 interacts with TPP1 and telomerase and sustains telomere leading‐strand replication [PDF]
Eukaryotic up-frameshift 1 (UPF1) is a nucleic acid-dependent ATPase and 5'-to-3' helicase, best characterized for its roles in cytoplasmic RNA quality control. We previously demonstrated that human UPF1 binds to telomeres in vivo and its depletion leads to telomere instability. Here, we show that UPF1 is present at telomeres at least during S and G2/M
Chawla Raghav +5 more
openaire +3 more sources
CTC1 OB-B interaction with TPP1 terminates telomerase and prevents telomere overextension
Abstract CST (CTC1-STN1-TEN1) is a telomere associated complex that binds ssDNA and is required for multiple steps in telomere replication, including termination of G-strand extension by telomerase and synthesis of the complementary C-strand.
Huan Wang +13 more
openaire +2 more sources
Recurrent TPP1 Promoter Mutations Drive Telomere Maintenance in Melanoma
Limitless replicative potential is a defining hallmark of cancer. Somatic cells are limited in their replicative potential by telomere shortening. Telomeres are caps on the ends of chromosomes that shorten as cells divide.
Chun-on, Pattra
core
TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma
Overcoming replicative senescence is an essential step during oncogenesis, and the reactivation of TERT through promoter mutations is a common mechanism. TERT promoter mutations are acquired in about 75% of melanomas but are not sufficient to maintain telomeres, suggesting that additional ...
Pattra Chun-on +11 more
openaire +4 more sources
Regulatory factor X-5 (RFX5) was previously characterized as an essential and highly specific regulator of major histocompatibility class II (MHCII) gene expression in the immune system. We found that RFX5 is significantly upregulated in hepatocellular carcinoma (HCC) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but ...
Yangjing, Zhao +9 more
openaire +3 more sources
Inflammation and Cancer: Molecular Mechanisms and Therapeutic Targets
Chronic inflammation fuels tumorigenesis via “internal drivers” and “external attractions.” Targeting these core mechanisms with combined therapies/novel deliveries enables precise, potent anti‐inflammatory–antitumor treatment. ABSTRACT Inflammation is a core pathological factor regulating tumor initiation, progression, and therapeutic resistance, and ...
Xiaodie Liu +4 more
wiley +1 more source
This proteomic study examines how nanofibers affect lung macrophages by analyzing protein changes following exposure to various fibrous materials. Nanofibers triggered the release of inflammatory enzymes, and importantly, lysosomal content release was identified as an early event associated with frustrated phagocytosis. Seventeen sensitive and relevant
Tobias Stobernack +9 more
wiley +1 more source
A Novel Human Cellular System for Studying Normal Aging and for Anti‐Aging Discovery
This study introduces a human cellular aging model using placental trophoblasts (hTSC‐STBs) that mimics key aging features like senescence and genomic instability. It aligns with human tissue aging and responds to anti‐aging treatments, offering a scalable platform to screen potential therapies and bridge lab findings to clinical applications ...
Zhen Feng +14 more
wiley +1 more source
Expression of TPP1 fusion proteins.
CHO cells were transiently transfected as indicated. Media was collected at 24) TPP1 and β-galactosidase activity measured in media and cell lysates. Data represents total activity in media (24 and 48-hour collection points) and cells.
Ling Huang (51752) +4 more
core +1 more source
Nonsense-Mutationen des TPP1-Gens bei cLINCL: Potential der Readthrough-Therapie
Die Tripeptidylpeptidase 1 (TPP1) ist eine lysosomale Serinprotease, die Tripeptide am N-Terminus von Polypeptiden abspaltet und somit an deren Abbau beteiligt ist. TPP1 wird als inaktives Proenzym synthetisiert und hat als solches eine Molekülmasse von
Kramer, Vivian
core +2 more sources

